Navigation Links
Novis Pharmaceuticals Opens New Location in San Luis Obispo, California
Date:7/11/2011

MIAMI, July 11, 2011 /PRNewswire/ -- Novis Pharmaceuticals, a leading distributor of critical care products, has officially opened their fifth office location in San Luis Obispo, California.  With more than 30 years of industry experience, Novis' aggressive plan to expand their national presence continues to move forward with news of this location opening.  Placed strategically between San Francisco and Los Angeles, Novis believes this will help capture parts of the regional market.  

The task of opening the new office was assigned to the new Vice President of Business Development, Robert Mankins.  Mankins brings more than 20 years of experience in sales management, business development and strategic planning and has worked for two of the "big three" pharmaceutical companies, Cardinal Health and Bergen Brunswig Drug Company.  Mankins noted that "Novis continues to bring advanced technologies into the critical care market with products like bar code scanning, trace and track and one of their our newest launches, RxID.  The combination of advanced technology for our customers and well equipped work spaces that allow employees to do their jobs well will be factors in the future success of Novis."  This building represents everything Novis has hoped for. "I believe from a recruiting and retention standpoint as well as the representation of our brand to our manufacturing partners, trading partners and customers, we will all be proud to claim this building as a regional home and extension to our daily efforts," states Mankins.  The design and layout capture not only the aesthetic quality that is a Novis standard, but the workflow and interaction space that is paramount to maximize efficiency.  One of Novis' goals for employees is for them to "love where you work." Mankins and his team are confident this new addition to the Novis offices will uphold that vision.

To learn more about Novis Pharmaceuticals, please visit their website at www.novispharma.com

Contact:  Melissa Lallo, 561-305-7008


'/>"/>
SOURCE Novis Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novis Pharmaceuticals Celebrates Four Years With New Website Launch
2. Vanda Pharmaceuticals Enters into an Exclusive License Agreement with Probiomed S.A. de C.V. for Commercialization of Fanapt™ in Mexico
3. Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting
4. Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International, Inc.
5. Topaz Pharmaceuticals Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs
6. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
7. Valeant Pharmaceuticals Agrees to Acquire Dermik
8. JHP Pharmaceuticals Launches New Multipack Presentations of Adrenalin®, Coly-Mycin® M and Pitocin®
9. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
10. Sigma-Tau Pharmaceuticals, Inc. Announces Addition of VP of Finance
11. Avanir Pharmaceuticals Announces Paragraph IV ANDA Filing for NUEDEXTA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):